SoCal.Startups is building the most comprehensive resource for Southern California's tech scene.
SoCal.Startups
Be an early user
Valora Therapeutics, Inc. hero photo
Valora Therapeutics, Inc. logo

Valora Therapeutics, Inc.

La Jolla, CA · Founded 2023
LAST FUNDING
$13.0M
Seed

Valora Therapeutics is developing AbLec™ multispecific antibodies and T-Lec™ T cell engagers — antibody-engineering platforms that decoy the glyco-immune checkpoint to create best-in-class therapeutics for cancer and autoimmune disease.

Funding history

RoundAmount
Seed$13.0M
SEC Form D filed
Jul 24, 2024

About Valora Therapeutics, Inc.

How much funding has Valora Therapeutics, Inc. raised?

Valora Therapeutics, Inc. has raised $13.0M in total funding. The most recent round was Seed.

Where is Valora Therapeutics, Inc. headquartered?

Valora Therapeutics, Inc. is headquartered in La Jolla, CA.

What does Valora Therapeutics, Inc. do?

Valora Therapeutics is developing AbLec™ multispecific antibodies and T-Lec™ T cell engagers — antibody-engineering platforms that decoy the glyco-immune checkpoint to create best-in-class therapeutics for cancer and autoimmune disease.

What problem does Valora Therapeutics, Inc. solve?

Cancer immunotherapies like PD-1/PD-L1 checkpoint inhibitors only work for a minority of patients because many tumors evade immune attack by cloaking themselves in sialic acid-rich glycans (the glyco-immune checkpoint).

What's Valora Therapeutics, Inc.'s solution?

Valora is developing multispecific AbLec antibodies and T-Lec T cell engagers that decoy the glyco-immune checkpoint to remove this immunosuppressive shield and drive stronger immune killing of cancer cells.

What makes Valora Therapeutics, Inc. different?

Its proprietary AbLec/T-Lec platform, invented by Dr. Jessica Stark in Dr. Carolyn Bertozzi's Stanford lab, is built specifically to target the glyco-immune checkpoint, a mechanism the company says prior therapies don't address.

What makes Valora Therapeutics, Inc. notable?

Co-founded by Nobel Prize-winning chemist Carolyn Bertozzi (2022 Nobel Prize in Chemistry) as scientific founder; the company raised a $30 million seed round in 2024.

Leadership

Miguel Garcia-Guzman
Executive Officer, Director
Stefan Heller
Director
Sanford Madigan
Director
Industry
Healthcare
Founded
2023
HQ
La Jolla, CA
Raised
$13.0M
Stage
Seed

Related terms

❝ Cite this page

Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated September 3, 2026.

MLA
"Valora Therapeutics, Inc.: Funding & Investors." SoCal.Startups, September 3, 2026, https://socalstartups.io/companies/valora-therapeutics-inc. Accessed September 28, 2026.
APA
SoCal.Startups. (2026). Valora Therapeutics, Inc.: Funding & Investors. Retrieved September 28, 2026, from https://socalstartups.io/companies/valora-therapeutics-inc
WIKIPEDIA (CITE WEB)
{{cite web |title=Valora Therapeutics, Inc.: Funding & Investors |url=https://socalstartups.io/companies/valora-therapeutics-inc |website=SoCal.Startups |access-date=September 28, 2026}}
🏷 Embed this badge

Building or fundraising? Add this to your site to show you're listed on SoCal.Startups — the link back helps other founders and investors find you here too.

Valora Therapeutics, Inc. featured on SoCal.Startups
HTML
<a href="https://socalstartups.io/companies/valora-therapeutics-inc" target="_blank" rel="noopener"><img src="https://socalstartups.io/badge.svg" width="220" height="52" alt="Valora Therapeutics, Inc. featured on SoCal.Startups" /></a>
MARKDOWN
[![Valora Therapeutics, Inc. featured on SoCal.Startups](https://socalstartups.io/badge.svg)](https://socalstartups.io/companies/valora-therapeutics-inc)